Boston, MA - A paclitaxel-coated balloon may end up filling a role never successfully filled by drug-eluting stents (DES): angioplasty of the leg. According to Dr Gunnar Tepe ...
Please provide your email address to receive an email when new articles are posted on . Orbital atherectomy was no better than balloon angioplasty for treatment of certain severely calcified coronary ...
Washington, DC - As Cutting Balloon TM (Boston Scientific, Natick, MA) angioplasty has struggled to find a niche in the world of interventional cardiologyespecially in light of two previous randomized ...
A drug-eluting resorbable stent was found to be just as effective in treating infrapopliteal artery disease in patients at risk of limb amputation, according to a study published Oct. 25 in the New ...
Drug-coated balloons are gaining attention as a stent-free angioplasty option, offering a “leave nothing behind” approach ...
Please provide your email address to receive an email when new articles are posted on . Balloon pulmonary angioplasty improved exercise capacity and quality of life in patients with chronic ...
A new drug-eluting balloon can perform just as well as the standard treatment for patients with coronary in-stent restenosis (ISR) undergoing repeated percutaneous coronary intervention (PCI). These ...
Submaximal balloon angioplasty for symptomatic intracranial atherosclerotic stenosis (ICAS) improved outcomes over aggressive medical management alone, the BASIS trial from China showed. The incidence ...
Jerry Bailey was awake while a medical team at OhioHealth Mansfield Hospital reopened one of his previously stented arteries using a new heart procedure. "It's working," the 73-year-old said a few ...
Blood clots in the lungs can prevent proper blood flow, which causes an increase in pressure in the affected blood vessels. This can lead to experiencing shortness of breath, chest pains, and have a ...
First In-Man Experience Exceeds Expectations, Cited as “Game Changer” for Below-the-Knee Procedures CAMBRIDGE, Mass.--(BUSINESS WIRE)--Summa Therapeutics, LLC announced today that the first-in-man ...